Jun 27 |
Tourmaline Bio promotes Ryan Robinson to CFO post
|
Jun 27 |
Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer
|
May 23 |
Tourmaline Bio to Present at the Jefferies Global Healthcare Conference
|
May 16 |
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
|
May 13 |
Tourmaline Bio GAAP EPS of -$0.55
|
May 13 |
Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
|
Apr 2 |
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
|
Mar 22 |
Tourmaline Bio: Sinking On Rival's Stodgy Data - I'm Slightly Bearish
|
Mar 19 |
Tourmaline Bio GAAP EPS of -$8.87
|
Mar 19 |
Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
|